New Key Statistics Module, Z-Score and F-Score
SZSE:300723 Key Ratios
Market Cap ¥ M | 9,028.37 |
Enterprise Value ¥ M | 9,698.33 |
P/E(ttm) | 50.20 |
PE Ratio without NRI | 48.73 |
Forward PE Ratio | -- |
Price/Book | 3.44 |
Price/Sales | 3.61 |
Price/Free Cash Flow | 58.83 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.49 |
Revenue (TTM) ¥ M | 2,410.00 |
EPS (TTM) ¥ | 0.40 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.90 |
y-y EBITDA Growth Rate % | -33.10 |
EV-to-EBIT | 36.08 |
EV-to-EBITDA | 36.08 |
PEG | 3.51 |
Shares Outstanding M | 454.14 |
Net Margin (%) | 7.22 |
Operating Margin % | 10.95 |
Pre-tax Margin (%) | 9.50 |
Quick Ratio | 0.85 |
Current Ratio | 1.05 |
ROA % (ttm) | 3.96 |
ROE % (ttm) | 7.10 |
ROIC % (ttm) | 4.41 |
Dividend Yield % | 1.04 |
Altman Z-Score | 4.13 |
SZSE:300723 Number of Guru Trades
SZSE:300723 Volume of Guru Trades
Gurus Latest Trades with SZSE:300723
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300723 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ApicHope Pharmaceutical Co Ltd Insider Transactions
No Available Data